Abstract
The mixed dissociation constant of azathioprine—chemically 6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H- purine at various ionic strengths I of range 0.01-0.2, and at temperatures of 25℃ and 37℃, was determined with the use of two different multiwavelength and multivariate treatments of spectral data, SPECFIT32 and SQUAD(84) nonlinear regression analyses and INDICES factor analysis according to a general rule. First, the number of components is determined, and then the spectral responses and concentrations of the components are calculated. Concurrently, the experimental determination of the thermodynamic dissociation constant was in agreement with its computational prediction of the PALLAS programme based on knowledge of the chemical structures of the drug. The factor analysis in the INDICES programme predicts the correct number of two light-absorbing species L- and HL. The thermodynamic dissociation constant of azathioprine was estimated by nonlinear regression of {pKa, I} data, = 8.07(1) at 25℃ and 7.84(1) at 37℃, where the figure in brackets is the standard deviation in last significant digits. The reliability of the dissociation constants of azathioprine was proven with goodness-of-fit tests of the multiwavelength spectrophotometric pH-titration data.
Highlights
Azathioprine [1], an immunosuppressant, is a drug that is used to suppress the immune system
SQUAD(84) nonlinear regression analyses and INDICES factor analysis according to a general rule
The apparatus used and the pH-spectrophotometric titration procedure have been previously described in details [18,19,20,21,25,26]
Summary
Azathioprine [1], an immunosuppressant, is a drug that is used to suppress the immune system. It is used to treat patients who have undergone kidney transplantation and for diseases in which activity of the immune system is important (psoriasis, severe cutaneous lupus erythematosus, rheumatoid arthritis, severe atopic dermatitis (eczema), cutaneous vasculitis etc.). Azathioprine is a prodrug (a precursor of a drug) which is converted in the body to its active form called mercaptopurine (Purinethol). The exact mechanism of action of azathioprine is not known. Like other immunosuppressants, it suppresses the proliferation of T and B lymphocytes, types of white blood cells that are part of the immune system and defend the body against both infectious diseases and foreign materials. In the case of autoimmune diseases (diseases caused by an abnormal immune reaction against the body’s own tissues) such as rheumatoid arthritis, suppressing the immune system reduces the inflammation that accompanies immune reactions and slows damage to the joints caused by the inflammation
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
